1 |
Danen, E. H. P., Sonneveld, P., Brakebusch, C., Fassler, R. and Sonnenberg, A. (2002). The fibronectin-binding integrins and differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J. Cell Biol. 159, 1071-1086
DOI
ScienceOn
|
2 |
Hernandez-Barrantes, S., Toth, M., Bernardo, M. M., Yurkova, M., Gervasi, D. C., Raz, Y., Sang, Q. A. and Fridman, R. (2000). Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275, 12080-12089.
DOI
ScienceOn
|
3 |
Kim, I. Y., Jeong, S. J., Kim, E. S., Kim, S. H. and Moon, A. (2007). Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in breast epithelial cells. J. Biochen. Mol. Biol. 40, 825-831
DOI
ScienceOn
|
4 |
Ryu, S., Jimi, S., Eura, Y., Kato, T. and Takebayashi, S. (1999). Strong intracellular and negative peripheral expression of fibronectin in tumor cells contribute to invasion and metastasis in papillary thyroid carcinoma. Cancer Lett. 146, 103-109
DOI
ScienceOn
|
5 |
Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Choi Kim, H. R. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer 85, 176-181
DOI
ScienceOn
|
6 |
Stanton, H., Gavrilovic, J., Atkinson, S. J., d'Ortho, M. P., Yamada, K. M., Zardi, L. and Murphy, G. (1998). The activation of proMMP-2 (gelatinase A) by HT-1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Science 111, 2789-2798
|
7 |
Brakebusch, C., Bouvard, D., Stanchi, F., Sakai, T. and Fa.ssler, R. (2002). Integrins in invasive growth. J. Clin. Invest. 109, 999-1006
DOI
ScienceOn
|
8 |
Watson, D. M., Elton, R. A., Jack, W. J., Dixon, J. M., Chetty, U. and Miller, W. R. (1991). The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res. Treat. 17, 161-169
DOI
|
9 |
Akiyama, S. K., Olden, K. and Yamada, K. M. (1995). Fibronectin and integrins in invasion and metastasis. Cancer Metastasis. Rev. 14, 173-189
DOI
|
10 |
Arihiro, K., Inai, K., Kurihara, K., Takeda, S. and Kaneko, M. (1993). Distribution of laminin, type IV collagen and fibronectin in the invasive component of breast carcinoma. Acta. Pathol. Jpn. 43, 758-764
DOI
|
11 |
Curran, S. and Murray, G. I. (1999). Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189, 300-308
DOI
ScienceOn
|
12 |
Clark, G. J. and Der, C. J. (1995). Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 35, 133-144
DOI
|
13 |
Das, S., Banerji, A., Frei, E. and Chatterjee, A. (2008). Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibro nectin in serum free medium. Life Sciences 82, 467-476
DOI
ScienceOn
|
14 |
Ding, J., Li, D., Wang, X., Wang, C. and Wu, T. (2008). Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell. Hepatogastroenterology. 55, 2072-2076
|
15 |
Clair, T., Miller, W. and Cho-Chung, Y. (1987). Prognostic significance of the expression of the ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res. 49, 5290-5293
|
16 |
Ohnishi, T., Hiraga, S., Izumoto, S., Matsumura, H., Kanemura, Y., Arita, N. and Hayakawa, T. (1998). Role of fibronectinstimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin. Exp. Metastasis. 16, 729-741
DOI
ScienceOn
|
17 |
Enam, S. A., Rosenblum, M. L. and Edvardsen, K. (1998). Role of extracellular matrix in tumor invasion: migration of glioma cells along fibronectin-positive mesenchymal cell processes. Neurosurg. 42, 599-608
DOI
ScienceOn
|
18 |
Fidler, I. J. (1990). Critical factors in the biology of human cancer metastasis. Cancer Res. 50, 6130-6138
|
19 |
Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. and He, C. S. (1989). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA. 86, 8207-8211
DOI
ScienceOn
|
20 |
Ito, H., Duxbury, M., Benoit, E., Farivar, R. S., Gardner-Thorpe, J., Zinner, M. J., Ashley, S. W. and Whang, E. E. (2004). Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 318, 594-600
DOI
ScienceOn
|
21 |
Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T. and Seiki, M. (2001). Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20, 4782-4793
DOI
ScienceOn
|
22 |
Juliano, R. L. (2002). Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 42, 283-323
DOI
ScienceOn
|
23 |
Kaspar, M., Zardi, U. and Neri, D. (2006). Fibronectin as target for tumor therapy. Int. J. Cancer. 118, 1331-1339
DOI
ScienceOn
|
24 |
Kim, M. S., Lee, E. J., Choi kim, H. R. and Moon, A. (2003). p38 kinase is a key signaling molecule for H-ras-induced cell motility and invasive phenotype in human breast epithelial cell. Cancer Res. 63, 5454-5461
|
25 |
Kleiner, D. E. and Stetler-Stevenson, W. G. (1999). Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43, 42-51
DOI
ScienceOn
|
26 |
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, J., Foltz, C. M. and Shafie, S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68
DOI
ScienceOn
|
27 |
Munshi, H. and Stack, M. S. (2006). Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 25, 45-56
DOI
|
28 |
Song, H., Ki, S. H., Kim, S. G. and Moon, A. (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496
DOI
ScienceOn
|
29 |
Sato, H., Takino, T. and Miyamori, H. (2005). Roles of membranetype matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 96, 212-217
DOI
ScienceOn
|
30 |
Seiki, M. (2002). The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 14, 624-632
DOI
ScienceOn
|
31 |
Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Bio. 9, 541-573
DOI
|
32 |
Yu, A. E., Hewitt, R. E., Kleiner, D. E. and Stetler-Stevenson, W. G. (1996). Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2. Biochem. Cell Biol. 74, 823-831
DOI
ScienceOn
|
33 |
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1995). Mechanism of cell surface activation of 72kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338
DOI
ScienceOn
|
34 |
Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C. and Klein-Szanto, A. J. P. (1989). Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogenetransformed human bronchial epithelial cells. Cancer Res. 49, 4615-4621
|
35 |
Wang, Z., Juttermann, R. and Soloway, P. D. (2000). TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415
DOI
ScienceOn
|